Huajian Healthcare Launches IVDNewCo Exchange Ecosystem for Medical Innovation

Huajian Healthcare, a company listed on the Hong Kong Stock Exchange, has announced the launch of the "IVDNewCo Exchange" ecosystem. This initiative includes the introduction of the world's first RWA trading platform focused on high-tech assets in the medical innovation pharmaceutical field, along with the issuance of the IVDD stablecoin.

The "IVDNewCo Exchange" ecosystem is part of a strategic initiative to build a "NewCo + RWA + Web3" trading platform. This platform aims to integrate Web3 technology, including real-world asset (RWA) tokenization, blockchain transactions, and stablecoin mechanisms, to enhance the liquidity, financing efficiency, and accessibility of global medical innovation pharmaceutical assets.

By leveraging these technologies, Huajian Healthcare seeks to disrupt traditional pharmaceutical industry norms. The ecosystem will provide a more efficient and accessible way to trade and finance high-tech medical assets, potentially revolutionizing the way pharmaceutical innovations are brought to market.

The IVDD stablecoin, a proprietary stablecoin issued by Huajian Healthcare, will play a crucial role in this ecosystem. It will facilitate transactions and provide a stable medium of exchange within the platform, ensuring that participants can conduct business with confidence.

This strategic move by Huajian Healthcare underscores the company's commitment to innovation and its vision for the future of the pharmaceutical industry. By embracing Web3 technology and RWA tokenization, the company is positioning itself at the forefront of a new era in medical innovation.